PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen announced today that it has signed a definitive agreement to acquire County Line Pharmaceuticals (“County Line”), a specialty generic pharmaceutical company based in Wisconsin, U.S. The transaction price is not disclosed.
Founded in 2007, County Line focuses on under-appreciated generic assets and specialty generic products. It has a balanced portfolio that spans multiple dosage forms including oral solutions, creams, ointments, gels and orally disintegrating tablets with 12 marketed products in the U.S. and leading positions across all its commercial product areas. In addition, it has a well-diversified pipeline, with 9 approvals and launches expected in 2016 and 8 more approvals in 2017, supported by a strong medium-term pipeline. County Line has a proven track record of high quality and consistent supply, supported by a reliable supply chain.
